(Q42651534)

4 November 2017

title

Potential effectiveness and safety of olanzapine in refractory panic disorder (English)

1 reference

4 November 2017

Michael Hollifield

1

1 reference

4 November 2017

Peter M Thompson

series ordinal

2

1 reference

4 November 2017

James E Ruiz

series ordinal

3

1 reference

4 November 2017

E H Uhlenhuth

series ordinal

4

1 reference

4 November 2017

publication date

1 January 2005

1 reference

4 November 2017

published in

Depression and Anxiety

1 reference

4 November 2017

volume

21

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

33-40

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

4 November 2017

cites work

1 reference

Panic disorder and quality of life: variables predictive of functional impairment

21 January 2018

1 reference

Six-month prevalence of psychiatric disorders in three communities 1980 to 1982.

21 January 2018

1 reference

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

The cross-national epidemiology of panic disorder

21 January 2018

1 reference

International Quality of Life Assessment (IQOLA) Project.

21 January 2018

1 reference

7 January 2021

How psychiatrists can build new therapies for impotence

1 reference

7 January 2021

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

7 January 2021

A rating scale for drug-induced akathisia

1 reference

7 January 2021

Panic disorder associated with clozapine

1 reference

7 January 2021

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

1 reference

7 January 2021

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

7 January 2021

A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder

1 reference

7 January 2021

Determinants of pharmacologic treatment failure in panic disorder.

1 reference

7 January 2021

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

7 January 2021

Panic and panic disorder in the United States

1 reference

7 January 2021

Olanzapine and panic attacks

1 reference

7 January 2021

Epidemiology of anxiety disorders in Florence.

1 reference

7 January 2021

Anxiety and depression in a village in Lesotho, Africa: a comparison with the United States.

1 reference

7 January 2021

Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear

1 reference

7 January 2021

The epidemiology of panic symptomatology and agoraphobic avoidance

1 reference

7 January 2021

Atypical antipsychotics for treatment of mixed depression and anxiety

1 reference

7 January 2021

Usefulness of olanzapine in refractory panic attacks.

1 reference

7 January 2021

Panic attacks in the community. Social morbidity and health care utilization

1 reference

7 January 2021

Olanzapine-associated diabetes mellitus

1 reference

7 January 2021

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

7 January 2021

Assessing impairment in patients with panic disorder: the Sheehan Disability Scale

1 reference

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

7 January 2021

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

7 January 2021

Olanzapine treatment for post-traumatic stress disorder: an open-label study

1 reference

7 January 2021

Sertraline treatment of panic disorder: results of a long-term study

1 reference

7 January 2021

Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder

1 reference

7 January 2021

The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies

1 reference

7 January 2021

Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder

1 reference

7 January 2021

Suicidal ideation and suicide attempts in panic disorder and attacks.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20050

1 reference

4 November 2017

1 reference